Tumor immune escape by the loss of homeostatic chemokine expression

被引:0
|
作者
Pivarcsi, A.
Mueller, A.
Rieker, J.
Steinhoff, M.
Kubitza, R.
Meller, S.
Sonkoly, E.
van Lierop, A.
Hoffmann, T. K.
Schneider, L.
Piekorz, R.
Enderlein, E.
Reifenberger, J.
Rohr, U.
Haas, R.
Boukamp, P.
Haase, I.
Nuernberg, B.
Ruzicka, T.
Zlotnik, A.
Homey, B.
机构
[1] Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany
[2] Univ Dusseldorf, Dept Radiat Oncol, D-4000 Dusseldorf, Germany
[3] Univ Munster, Dept Dermatol, D-4400 Munster, Germany
[4] Univ Dusseldorf, Dept Otorhinolaryngol, D-4000 Dusseldorf, Germany
[5] Univ Dusseldorf, Dept Biochem, D-4000 Dusseldorf, Germany
[6] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany
[7] German Canc Res Ctr, Dept Genet Skin Carcinogenesis, D-6900 Heidelberg, Germany
[8] Univ Cologne, Dept Dermatol, D-5000 Cologne, Germany
[9] Neurocrine Biosci Inc, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:260 / 260
页数:1
相关论文
共 50 条
  • [41] LOSS OF TATA FROM CLONED TUMOR CELL-LINES - AN EXAMPLE OF IMMUNE ESCAPE DURING TUMOR-METASTASIS AND PROGRESSION
    BOSSLET, K
    SCHIRRMACHER, V
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1981, 99 (03) : A65 - A66
  • [42] Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells
    Huang, Renxiang
    Zhang, Dongyang
    Li, Feng
    Xiao, Zili
    Wu, Meilin
    Shi, Dongyun
    Xiang, Ping
    Bao, Zhijun
    ONCOLOGY LETTERS, 2017, 13 (05) : 3379 - 3386
  • [43] MHC class I antigens, immune surveillance, and tumor immune escape
    Garcia-Lora, A
    Algarra, I
    Garrido, F
    JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (03) : 346 - 355
  • [44] Tumor-promoting immune cells: Cancer immune escape and beyond
    Domblides, Charlotte
    Alizadeh, Darya
    Larmonier, Nicolas
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape
    Ignacio Algarra
    Angel García-Lora
    Teresa Cabrera
    Francisco Ruiz-Cabello
    Federico Garrido
    Cancer Immunology, Immunotherapy, 2004, 53 : 904 - 910
  • [46] The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules:: implications for tumor immune escape
    Algarra, I
    García-Lora, A
    Cabrera, T
    Ruiz-Cabello, F
    Garrido, F
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (10) : 904 - 910
  • [47] Analysis of HLA surface expression and the tumor microenvironment in Hodgkin lymphoma as a potential tumor immune escape mechanism in Egyptian patients
    Ayoub, Mariam
    HLA, 2023, 101 (04) : 371 - 372
  • [48] Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
    Saranchova, Iryna
    Han, Jeffrey
    Huang, Hui
    Fenninger, Franz
    Choi, Kyung Bok
    Munro, Lonna
    Pfeifer, Cheryl
    Welch, Ian
    Wyatt, Alexander W.
    Fazli, Ladan
    Gleave, Martin E.
    Jefferies, Wilfred A.
    SCIENTIFIC REPORTS, 2016, 6
  • [49] Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
    Iryna Saranchova
    Jeffrey Han
    Hui Huang
    Franz Fenninger
    Kyung Bok Choi
    Lonna Munro
    Cheryl Pfeifer
    Ian Welch
    Alexander W. Wyatt
    Ladan Fazli
    Martin E. Gleave
    Wilfred A. Jefferies
    Scientific Reports, 6
  • [50] Noncoding RNAs: the shot callers in tumor immune escape
    Lei Liu
    Qin Wang
    Zhilin Qiu
    Yujuan Kang
    Jiena Liu
    Shipeng Ning
    Yanling Yin
    Da Pang
    Shouping Xu
    Signal Transduction and Targeted Therapy, 5